Stevanato Group Expands with New Facility for Advanced Pre-Sterilized Syringe Production in Cisterna di Latina
Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life science industries, today announced the inauguration of its Cisterna di Latina plant.
Located just a few kilometers from the Group's first historic plant in Latina, the new site covers an area of 65,000 square meters and employs around 200 people. The facility started commercial production in Q4 2023 and houses advanced production lines developed by Stevanato Group for the production of EZ-fill® pre-sterilized syringes with the aim of responding to the modern challenges of the European market, constantly growing in biopharmaceuticals, such as GLP-1s. Furthermore, the Company is planning to implement production with EZ-fill® pre-sterilized cartridges between 2025 and 2026 as the site becomes fully operational.